Skip to main content
Clinical Trials/TCTR20240316003
TCTR20240316003
Completed
Phase 1

eurosurgical Sepsis And Septic Shock Protocols After Craniotomy Clinical Outcomes And Survival Analysis.

Phramongkutklao Hospital Foundation0 sites139 target enrollmentMarch 16, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Central nervous system infection is a factor associated with an increase in perioperative mortality. Post-operative neurosurgical infection still highly prevalent and lethal syndrome. Nowadays, the Surviving Sepsis Campaign (SSC) has been developed as a guideline, but no study explores the clinical outcome.
Sponsor
Phramongkutklao Hospital Foundation
Enrollment
139
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 16, 2024
End Date
January 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Phramongkutklao Hospital Foundation

Eligibility Criteria

Inclusion Criteria

  • All consecutive neurosurgical patients with sepsis and septic shock admitted to the neurosurgical intensive care unit.

Exclusion Criteria

  • The patients that refused to study.
  • The patients that had pre\-existing systemic disease.
  • The patients that were significantly limiting life expectancy.
  • The patients that were transferred to tertiary care hospital.
  • The patients that were intolerance to protocol.
  • The patients that were pulmonary embolism.
  • The patients that were congestive heart failure or acute myocardial infarction.

Outcomes

Primary Outcomes

Not specified

Similar Trials